Showing 1 - 9 results of 9 for search 'I. S. Ilgisonis', query time: 0.03s
Refine Results
-
1
-
2
-
3
-
4
INFLUENCE OF THE COMBINATION DRUG PRESTANS (PERINDOPRIL A, AMLODIPINE) ON MORPHO-FUNCTIONAL PARAMETERS OF ARTERIAL BED IN ESSENTIAL HYPERTENSION by Yu. A. Danilogorskaya, E. A. Zheleznykh, E. V. Privalova, A. A. Shchendrygina, Yu. N. Belenkov, I. S. Ilgisonis, M. I. Tishman
Published 2017-12-01Get full text
Article -
5
Changes of myocardial dysfunction and injury biomarkers over chemotherapy for multiple myeloma: difficulties in laboratory data interpretation by E. V. Fomina, S. A. Kardovskaya, D. A. Budanova, P. A. Markin, S. A. Appolonova, A. S. Lishuta, Yu. N. Belenkov, I. S. Ilgisonis
Published 2023-11-01Get full text
Article -
6
-
7
Study of proinflammatory markers, galectin-3 level, lipid metabolism parameters, cardiovascular status and their relationship in patients with lymphomas before antitumor therapy by I. Ya. Sokolova, S. A. Kardovskaya, E. Yu. Salakheeva, Yu. Yu. Kirichenko, E. A. Siderko, O. V. Bochkarnikova, A. A. Shchendrygina, Yu. N. Belenkov, I. S. Ilgisonis
Published 2025-03-01Get full text
Article -
8
Vascular Remodeling Markers in Patients with Essential Arterial Hypertension Depending on Presence of Type 2 Diabetes Mellitus by Yu. A. Danilogorskaya, E. A. Zheleznykh, E. A. Privalova, Yu. N. Belenkov, A. A. Shchendrigina, M. V. Kozhevnikova, G. A. Shakaryants, V. Y. Zektser, A. S. Lishuta, I. S. Ilgisonis
Published 2019-07-01Get full text
Article -
9
Left Atrium Involvement in Lymphoma Patients: Single Center Observational Study by E. Yu. Salakheeva, I. Ya. Sokolova, O. V. Lyapidevskaya, K. A. Zhbanov, S. A. Tsatsurova, N. I. Kanevskiy, V. O. Stebakova, E. V. Privalova, I. S. Ilgisonis, Yu. N. Belenkov, A. A. Shchendrygina
Published 2022-09-01Get full text
Article